glp-1 therapy protein intake optimization research Frontiers What is GLP-1? The Hormone

The doses of liraglutide or semaglutide are different depending on whether the patient has DT2, is overweight (BMI 27kg/m2) with comorbidities or has obesity (with or without DT2)

[DOI] [PMC free article] [PubMed] [Google Scholar] 148

A member has an intake visit, receives a prescription, checks in occasionally, and continues treatment indefinitely or stops once a weight goal is reached, often without support to sustain progress

Researchers found that people who took semaglutide lost, on average, 3.6% of their body weight after three months

it encourages the body to rebuild its natural collagen

[DOI] [PubMed] [Google Scholar] Bulchandani D, Nachnani JS, Herndon B, Molteni A, Pathan MH, Quinn T, Hamdan HA, Alba LM, Graves L